MedDataX Logo

Ultrasound to Check the Position of the Nasogastric Tube

NCT ID: NCT06635915

Last Updated: 2024-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

114 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-10-15

Study Completion Date

2025-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to evaluate whether the use of ultrasound as a method of checking the normal positioning of the NGT is reliable, without requiring other diagnostic tests. Clinical trial that will include patients who had the NGT placed intraoperatively. 114 patients (57 with NGT and 57 without NGT) will be examined by ultrasound in the immediate postoperative period to diagnose the normal positioning of the NGT or its absence.

Can ultrasound quickly and effectively diagnose the normal positioning of the NGT? Can chest X-ray be avoided by introducing ultrasound in the verification of the normal positioning of the NGT in the immediate postoperative period?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The nasogastric tube (NGT) is an essential element of our daily clinical practice, commonly used for the administration of enteral nutrition and medication or for gastric decompression and diagnostic procedures. Despite its common use, it is still an invasive procedure with potential complications. Ultrasound is a noninvasive, inexpensive, widely available and rapid method that can speed up the proper verification of these devices. The main objective of this study is to evaluate whether the use of ultrasound as a method of checking the normal positioning of the NGT is reliable, without requiring other diagnostic tests. Clinical trial that will include patients who had the NGT placed intraoperatively. 114 patients (57 with NGT and 57 without NGT) will be examined by ultrasound in the immediate postoperative period to diagnose the normal positioning of the NGT or its absence. Patients who have had the NGT placed will have had their NGT placed correctly by chest X-ray. The upper part of the patient will be covered for the examiner, who will only have access to the patient's abdomen and will not know which patients have NGT or not.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nasogastric Tube Placement

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

nasogastric tube placement ultrasound postoperative diagnosis monitoring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Clinical trial that will include patients who have had NGT placed intraoperatively. 114 patients (57 with NGT and 57 without NGT) will be examined by ultrasound in the immediate postoperative period to diagnose the normal positioning of the NGT or its absence. In patients who have had NGT placed, the normal positioning of the NGT will be verified by chest X-ray.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Caregivers Investigators
The upper part of the patients will be covered for the investigator, who will only have access to the patient's abdomen and will not know which patients have NGT or not.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with nasogastric tube placed during the intraoperative period.

Ultrasound will be performed during the postoperative period to assess the normoposition of nasogastric tube.

Group Type EXPERIMENTAL

Postoperative ultrasound

Intervention Type DIAGNOSTIC_TEST

Ultrasound will be performed to both groups in the postoperative period to assess the normoposition or the absence of nasogastric tube.

Patients without nasogastric tube placed during the intraoperative period.

Ultrasound will be performed during the postoperative period to assess the absence of nasogastric tube.

Group Type ACTIVE_COMPARATOR

Postoperative ultrasound

Intervention Type DIAGNOSTIC_TEST

Ultrasound will be performed to both groups in the postoperative period to assess the normoposition or the absence of nasogastric tube.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Postoperative ultrasound

Ultrasound will be performed to both groups in the postoperative period to assess the normoposition or the absence of nasogastric tube.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients classified as ASA I-IV according to the American Society of Anesthesiologists
* Patients over 18 years old.
* Informed consent signed by the patient or their family representatives

Exclusion Criteria

* Patients classified as ASA V.
* Patients under 18 years old.
* Refusal to participate in the study.
* Contraindication for nasogastric tube placement: ingestion of caustics, nasal or skull fractures, and cervical surgery.
* Patients with anatomical abnormalities at the cervical or pharyngoesophageal level.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Dr. Negrin University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ángel Becerra

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Universitario de Gran Canaria Doctor Negrín

Palmas de GRAN Canaria, LAS, Las Palmas, Spain

Site Status RECRUITING

Hospital Universitario de Gran Canaria Doctor Negrín

Las Palmas de Gran Canaria, , Spain

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Angel Becerra-Bolaños, MD PhD

Role: CONTACT

Phone: +34928450370

Email: [email protected]

Aurelio Rodríguez-Pérez, MD PhD

Role: CONTACT

Phone: +34928450370

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ángel Becerra-Bolaños, MD PhD

Role: primary

Aurelio Rodríguez-Pérez, MD PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-300-1

Identifier Type: -

Identifier Source: org_study_id